Daily market recaps with key events, stock movements, and global influences 8 posts • GPT (4.1 mini) Published May 18, 2025, 08:24 AM Researchers led by Drs. Kiran Musunuru of the University of Pennsylvania and Rebecca Ahrens-Nicklas of the Children's Hospital of Philadelphia have achieved a groundbreaking clinical application of base editing technology developed in the lab of Broad Institute member Dr. David Liu.
Is this you? As a journalist, you can create a free Muck Rack account to customize your profile, list your contact preferences, and upload a portfolio of your best work.
Claim your profile
Articles by NLS Optimization
Laboratory-Evolved CRISPR-Associated Transposase Enables Therapeutic Gene Insertion and Megabase-Scale Genome Rearrangement
Daily market recaps with key events, stock movements, and global influences 9 posts • GPT (4.1 mini) Updated May 17, 2025, 12:29 AM Researchers have made significant advances in genome editing by developing new CRISPR-associated transposase (CAST) variants capable of inserting entire genes into human DNA with high precision and efficiency.
Researchers Develop Megabase-Scale DNA Recombinases and evoCAST for Therapeutic Gene Insertion with Reduced CRISPR Off-Target Effects
Daily market recaps with key events, stock movements, and global influences 7 posts • GPT (4.1 mini) Published May 15, 2025, 07:41 PM Researchers at the Arc Institute have reported the discovery and engineering of the first programmable DNA recombinases capable of megabase-scale human genome rearrangement, marking a significant advancement in genome editing technology. In a separate development published in Science Magazine, a collaboration involving David R.
EviAnn Evidence-Based Genome Annotation Led by Aleksey Zimin Outperforms Tools, Completes Mammalian Genome in Under an Hour
8 posts ⢠GPT (4.1 mini) Updated May 15, 2025, 05:32 AM A new genome annotation software named EviAnn has been introduced, offering an efficient and evidence-based approach to genome annotation. Developed under the leadership of Aleksey Zimin, EviAnn derives protein-coding gene and long non-coding RNA annotations from RNA-seq data, transcripts, and protein alignments from related species.
Federal Circuit Vacates PTAB Decision, Reopens CRISPR Patent Dispute Between UC, Broad Institute, Nobel Laureates
Federal Circuit Vacates and Remands in Long-Pending Dispute over CRISPR IP https://t.co/UI0CgUyGXc | by @MoFoLLP Genmab to Present New and Updated Results from its Robust Epcoritamab (EPKINLY®) Development Program at the 2025 European Hematology Association (EHA) Congress $GMAB https://t.co/SCtpwi0Pd7 Enliven Therapeutics Announces Updated Positive Data from Phase 1 Clinical Trial of ELVN-001 in CML and Oral Presentation at the EHA 2025 Congress $ELVN https://t.co/84xtk8GG9L
Federal Circuit Revives CRISPR Patent Dispute, Remands UC and Broad Institute Case to PTAB
14 posts • GPT (4.1) Updated May 13, 2025, 04:57 PM The U.S. Court of Appeals for the Federal Circuit has revived the patent dispute over foundational CRISPR-Cas9 gene-editing technology, siding with the University of California and the University of Vienna in their challenge against the Broad Institute.
Federal Appeals Court Revives CRISPR Patent Dispute, Vacates PTAB Decision, Backed by Nobel Winners, Focuses on Eukaryotic Cells
9 posts • GPT (4.1 mini) Updated May 13, 2025, 12:29 PM A federal appeals court has revived the longstanding patent dispute over the CRISPR-Cas9 gene-editing technology, reopening the question of who holds the foundational patents. The court sided with the University of California (UC) Berkeley, vacating a prior Patent Trial and Appeal Board (PTAB) decision that had ruled against UC's claim of conception before the Broad Institute's October 2012 earliest priority date.
Federal Circuit Reopens CRISPR Patent Dispute Involving Editas Medicine, Nobel Winners, and Broad Institute Patents
Daily market recaps with key events, stock movements, and global influences 6 posts • GPT (4.1 mini) Published May 13, 2025, 12:20 AM The U.S. Court of Appeals for the Federal Circuit has ordered a re-evaluation of the CRISPR patent dispute, reopening the question of who holds the patents for the groundbreaking CRISPR gene-editing technology. This decision remands the case back to the Patent Trial and Appeal Board for further proceedings.
Barcelona Scientists Use AI to Design DNA Synthetic Enhancers That Switch Genes On and Off for Gene Therapy
Daily market recaps with key events, stock movements, and global influences 5 posts • GPT (4.1 mini) Published May 10, 2025, 08:53 AM A team of scientists in Barcelona has developed an artificial intelligence system capable of designing DNA fragments that can control the function of healthy mammalian cells. This breakthrough marks the first time AI-created DNA has been used to switch genes on and off in mammalian cells.
India Develops Genome-Edited Rice Free of Foreign DNA; FDA Approves CRISPR Gene-Edited Pigs with Improved Meat Quality
Daily market recaps with key events, stock movements, and global influences Gene-edited fruit and veg https://t.co/uGOmZvN5yv Innovative Breakthrough in Agri-tech: 'FDA Greenlights Gene-Hacked CRISPR Pigs!' In a landmark decision, the FDA has approved gene-edited pigs for human consumption.
India Launches Climate-Resilient Genome-Edited Rice With 20-30% Yield Boost, No Foreign Genes, and Reduced Water Use
6 posts • GPT (4.1 mini) Updated May 7, 2025, 11:59 AM India has launched the world’s first genome-edited rice varieties that are climate-resilient, yield 20-30% more rice, and do not contain foreign genes. These new rice strains are designed to boost agricultural productivity while reducing water consumption, according to Shivraj Singh Chouhan. The genome-editing technology used differs from traditional genetically modified organisms by avoiding the introduction of foreign DNA.
Genomic Studies Link GABA Signaling to Glioblastoma, Huntington’s Protein Dynamics, CRISPRi and eQTL Insights
Daily market recaps with key events, stock movements, and global influences 4 posts • GPT (4.1 mini) Published May 6, 2025, 07:36 PM Recent genomic research highlights advances in understanding disease mechanisms through gene regulatory networks and genetic perturbation screening. Studies have identified the role of GABA signaling in glioblastoma pathogenesis and explored convergent cell state dynamics via single-cell high-content CRISPR screening.
India Launches First Genome-Edited Rice Varieties by ICAR to Boost Yields and Reduce Costs, Water Use
5 posts • GPT (4.1 mini) Published May 4, 2025, 09:31 AM India's Agriculture Minister Shivraj Singh Chouhan launched the country's first two genome-edited rice varieties developed by the Indian Council of Agricultural Research (ICAR) in New Delhi. These new rice varieties are designed to reduce production costs, increase yields, require less water, and lower emissions, contributing to enhanced agricultural productivity and sustainability.
Show More
loading
Actions
Is this you?
As a journalist, you can create a free Muck Rack account to customize your profile, list your contact preferences, and upload a portfolio of your best work.Get in touch with NLS
Contact NLS, search articles and posts on X, monitor coverage, and track replies from one place.
Learn more about Muck Rack